Infinium Global Research has added a
new report on Global Antiviral Drugs Market: Trends Analysis and Forecast
2023. The report presents analysis
global as well as regional markets of Antiviral Drugs over the period of 2017
to 2023. Moreover, the IGR-Growth Matrix given in the report provides key focus
areas and investment areas the market players can focus on. The market size is
presented in terms of value for the historic year 2015 and estimated for
forecast period of 2017 to 2023.
The global Antiviral Drugs market was
dominated by the North America region followed by the Europe Antiviral Drugs
market with potential growth in both of this region, whereas Asia Pacific
anticipated growing at highest CAGR. Based on the countries US is the major
market for Antiviral Drugs globally followed by India, Germany, and UK.
Moreover, India has most HIV cases due which it is one of the most dynamic markets
across globe followed by US at second place. Increasing incidences of epidemics
in viral infections has played vital role and predominantly drives global
antiviral drugs market. Furthermore, strong research and development activities
in order to develop and introduce advanced drugs and advanced treatment and
formulations including vaccines and combination therapy and others have
encouraged demand for antiviral drugs.
Get Sample Copy of this Report: https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/765
Regionally, North America is the
largest and dominated market globally and it is anticipated to retain its
dominance by accounting largest market shares during forecast period of 2017 to
2023. The growth in this region can be credible to sophisticated healthcare
infrastructure as well as presence of leading market players in this region.
Whereas, Asia Pacific region expected to emerge as most dynamic region with
highest CAGR during forecast period. This is due to Indian market contribution
in the region growth followed by China and South Korea. The report covers the
analysis of global as well as regional markets of the Antiviral Drugs market.
Moreover the report provides deep
insights on demand forecasts, market trends and micro and macro indicators. In
addition, this report provides insights on the factors that are driving and
restraining the demand globally as well as regionally. Moreover, Infinium
Global Research- Growth Matrix (IGR- Growth Matrix) given in the report brings
an insight on the investment areas that existing or new market players can
consider.
The report provides insights into the
market using analytical tools such as Porter’s five forces analysis and value
chain analysis of Antiviral Drugs. Moreover, the study highlights current
market trends and provides forecast from 2017 to 2023. We also have highlighted
future trends in the Antiviral Drugs that will impact the demand during the
forecast period.
Complete report at: https://www.infiniumglobalresearch.com/healthcare_medical_devices/global_antiviral_drugs_market
The Infinium Global Research- Growth
Matrix (IGR- Growth Matrix) provided in this report highlights key investing
markets in the world. Moreover, the competitive analysis given in each regional
market brings an insight on the market share of the leading players.
Additionally, the analysis highlights rise and fall in the market shares of the
key players in the market. This report will help manufacturers, suppliers and
distributors to understand the present and future trends in this market and
formulate their strategies accordingly.
Global antiviral drugs market has grown
moderately over the past few years, but during the forecast period this market
likely to have healthy gains. As of 2023, as per the WHO 35.3 Mn people were
infected with HIV globally, hence increased in viral infection incidences
considered as one of the strong driving force in this market. Due to which
robust R&D activities, advanced treatments and formulations such as
vaccines, combination therapy, and others introduced in the market. Moreover,
Strong research and development activities have led to introduction of new
drugs with better efficacy and less side effects thereby contributing
significantly in the global growth. On the other hand, High risk of failure,
higher cost associated with research and development activities, and stringent
government regulations are the major growth barriers inhibiting global growth
of this market.
Increasing incidences of epidemics in
viral infections such as influenza, respiratory syncytial virus and others
anticipated to provide massive growth opportunities for this market over the
forecast period. Whereas, High cost associated with development of new drugs
and usage of natural products will pose as major challenge in front of this
market.
The report segments the global
antiviral drugs market by drug type, by therapeutics, by end user, and by
region. The market size of each segment has been provided in terms of value
(USD) and volume (tons). Market segmentation based on type includes branded
drugs and generic drugs. On the basis of therapeutics global market has been
divided into HIV/AIDS therapeutics, hepatitis (B&C) therapeutics, herpes
therapeutics, influenza therapeutics and others (Pneumonia). Market
segmentation based on end user includes hospitals, clinics, and ambulatory
surgical center
The companies covered in the report
include Roche Holding AG, Gilead, GlaxoSmithKline, Bristol-Myers-Squibb, Abbott
Healthcare, Med Immune/AstraZeneca, Schering-Plough, Johnson & Johnson,
Merck & Co, Gilead Sciences, Dr Reddy, and Cipla
Reasons to buy this report
1) Comprehensive analysis of global as
well as regional markets of Antiviral Drugs.
2) Complete coverage of all the type,
form, processing, and application segments to analyze the trends, developments,
and forecast of market size up to 2023.
3) Comprehensive analysis of the
companies operating in this market. The company profile includes analysis of
product portfolio, revenue, SWOT analysis and latest developments of the
company.
4) Infinium Global Research- Growth
Matrix presents analysis of the product segments and geographies that market
players should focus to invest, consolidate, expand and/or diversify.
About Us
Infinium Global Research and Consulting
Solutions is started with a single motto of being business partner of first
choice. We at Infinium work on the strengths of our clients to ensure we help
them consolidate their market position. We firmly believe in the fact that ‘if
you are able to develop newer opportunities then you find there is no dearth of
opportunities for you. With our strategic research approaches and deep dive in
the market segments, we try to find out new opportunities that our clients can
encash with their existing resources. Our experts with over 100 years of
cumulative experience in research offer the best in the industry services to
our clients to ensure that they achieve their business goals.
Contact Us
Infinium Global Research,
Toll Free:
U.S. + Canada: 1-800-638-0796,
UK: +44-2033182010
skype: Infiniumglobalresearch
No comments:
Post a Comment